Screen LibraryAngiogenesis modulations in health and disease practical applications of pro- and anti-angiogenesis targets /
This book is a major update of novel targets in angiogenesis modulation, including pro- and anti-angiogenesis. There is in-depth coverage of preclinical and clinical methods and models, investigational status, and clinical applications. The impact of nanotechnology in advancing the applications of p...
Saved in:
| Corporate Authors: | |
|---|---|
| Group Author: | ; |
| Published: |
|
| Literature type: | Electronic eBook |
| Language: | English |
| Subjects: | |
| Online Access: |
http://dx.doi.org/10.1007/978-94-007-6467-5 |
| Summary: |
This book is a major update of novel targets in angiogenesis modulation, including pro- and anti-angiogenesis. There is in-depth coverage of preclinical and clinical methods and models, investigational status, and clinical applications. The impact of nanotechnology in advancing the applications of pro-and anti-angiogenesis strategies is also highlighted, along with stem cell and biotechnologies in research and development of angiogenesis modulating targets. |
| Carrier Form: | 1 online resource (x, 206 p.) : ill. |
| Bibliography: | Includes bibliographical references and index. |
| ISBN: |
9789400764675 (electronic bk.) 9400764677 (electronic bk.) |
| Index Number: | QP106 |
| CLC: | R732 |
| Contents: |
Pro-angiogenesis Targets and Clinical Implications -- Survey of Pro-angiogenesis Strategies / Angiogenesis Modulation by Arachidonic Acid-derived Lipids: Positive and Negative Regulators of Angiogenesis / Pro-angiogenic Activity of Thyroid Hormone Analogues: Mechanisms, Physiology and Clinical Prospects / Actions of Steroids and Peptide Hormones on Angiogenesis / Role of Non-neuronal Nicotinic Acetylcholine Receptors in Angiogenesis Modulation / Catecholamine Neurotransmitters: An Angiogenic Switch in the Tumor Microenvironment / Impact of Nanotechnology on Therapeutic Angiogenesis / Anti-angiogenesis Targets and Clinical Applications -- Survey of Anti-angiogenesis Strategies / Tetraiodothyroacetic Acid (Tetrac), Nanotetrac and Anti-angiogenesis / Integrin Antagonists and Angiogenesis / Anti-angiogenesis Therapy as an Adjunct to Chemotherapy in Oncology / Anti-VEGF Strategies in Ocular Angiogenesis-mediated Disorders, with Special Emphasis on Age-related Macular Degeneration / Application of Nanotechnology to Prevent Tumor Angiogenesis for Therapeutic Benefit / Biomarkers of Response and Resistance to Anti-angiogenic Treatment / Speculations on New Directions in Which Angiogenesis May Proceed / |